News

Certa Honored in ProcureTech100 for AI-Driven Risk Management

Certa Honored in ProcureTech100 for AI-Driven Risk Management

Certa Recognized as a Leader in AI-Driven Risk Management

Certa, a prominent enterprise platform renowned for its capabilities in third-party risk, compliance, and ESG management, has been officially listed in the prestigious 2024 ProcureTech100. This recognition underscores Certa's commitment to innovation in digital procurement solutions. The ProcureTech100, a well-respected compilation established by ProcureTech in tandem with Kearney, showcases the most forward-thinking digital procurement tools available.

Highlights of the ProcureTech100 Selection

This year's selection process evaluated over 5,000 technological solutions through a rigorous series of assessments involving 80 global digital procurement authorities, industry experts, and financial investors. Solutions were assessed against fifteen distinct categories such as Innovation, Customer Satisfaction, and Advanced AI, ensuring that only the most relevant technologies were recognized.

Insights from Industry Experts

Dr. Elouise Epstein, Partner at Kearney, remarked on the ever-evolving landscape of procurement technology. She stated, "The procure tech space continues to be a powerful hub of innovation and inspiration. As we advance to the future, the market continues to grow and contract, which is a positive indicator of a dynamic ecosystem." This sentiment resonates strongly with Certa's commitment to leveraging technology to meet the challenges of the modern business landscape.

Innovative Generative AI Capabilities at Certa

Certa's inclusion in the ProcureTech100 not only highlights its technological advancements but also emphasizes the comprehensive generative AI capabilities embedded in its platform. By transforming unstructured data from contracts and reports, Certa enables organizations to derive actionable insights. Its innovative approach allows users to autofill questionnaires and streamline decision-making processes regarding third-party affiliations.

CEO's Vision for the Future

Jag Lamba, the CEO and Founder of Certa, expressed his enthusiasm about the platform's generative AI functionalities. He noted, "The ability to leverage artificial intelligence to analyze complex data signifies a fundamental shift in operational methodologies. Our technology transforms unstructured information into structured data, empowering organizations to make informed choices and efficiently manage their processes."

Key Features of Certa's Platform

The innovations within the Certa platform include:

  • AI-driven workflow design utilizing natural language.
  • Automated responses for questionnaires to simplify third-party onboarding.
  • Intelligent risk assessment leveraging various document types.
  • Plug-and-play ESG modules to ensure global compliance.
  • A redesigned user interface aimed at enhanced functionality.

Setting Industry Standards

Lance Younger, CEO of ProcureTech, acknowledged the challenges that organizations face in procurement. He stated, "The selected organizations in the 2024 ProcureTech100 are pioneers in the field, breaking through barriers for the industry and providing exceptional user experiences and scalability, solving both complex and simple procurement challenges." Certa's ongoing innovation reinforces its leadership within this dynamic ecosystem.

About Certa

Certa stands as the leading software platform that empowers enterprises to efficiently manage risks, compliance issues, and ESG assessments for their third-party relationships, encompassing vendors, partners, and clients. With over 130 integrations available, Certa's platform is designed to navigate the intricacies of regulations while ensuring strong, compliant, and sustainable third-party relationships.

About ProcureTech

ProcureTech is instrumental in accelerating the digital transformation in the procurement sector by addressing contemporary challenges through innovative strategies and solutions. Their collaborative efforts link procurement leaders, entrepreneurs, and the wider procuretech ecosystem for optimal results.

About Kearney

Kearney is a renowned global management consulting firm. With a workforce extending beyond 5,700 individuals across more than 40 nations, the firm collaborates with a significant portion of the Fortune Global 500 and other crucial global entities.

Frequently Asked Questions

What is the ProcureTech100?

The ProcureTech100 is an annual list that recognizes pioneering digital procurement solutions evaluated against multiple criteria for innovation and customer focus.

Why was Certa chosen for the ProcureTech100 list?

Certa was recognized for its advanced capabilities in third-party risk and compliance management, particularly its integration of generative AI technology.

What are the key features of Certa's platform?

Key features include AI-powered workflow design, automated questionnaire responses, intelligent risk assessment, and ESG compliance modules.

What trends are shaping the procure tech industry?

Current trends include the incorporation of artificial intelligence for data analysis, enhancing user experiences, and addressing complex procurement challenges dynamically.

How can companies benefit from using Certa's platform?

Organizations can streamline their third-party processes, make informed decisions, and ensure compliance while reducing the time and effort associated with manual processes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles